BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17136992)

  • 1. The role of oxidative stress in chronic obstructive pulmonary disease.
    Bowler RP; Barnes PJ; Crapo JD
    COPD; 2004; 1(2):255-77. PubMed ID: 17136992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
    Dailah HG
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
    Domej W; Oettl K; Renner W
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress-based therapeutics in COPD.
    Barnes PJ
    Redox Biol; 2020 Jun; 33():101544. PubMed ID: 32336666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
    Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
    Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease.
    Białas AJ; Sitarek P; Miłkowska-Dymanowska J; Piotrowski WJ; Górski P
    Oxid Med Cell Longev; 2016; 2016():7808576. PubMed ID: 28105251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
    Biswas S; Hwang JW; Kirkham PA; Rahman I
    Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS in the local and systemic pathogenesis of COPD.
    Langen RC; Korn SH; Wouters EF
    Free Radic Biol Med; 2003 Aug; 35(3):226-35. PubMed ID: 12885585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lentivirus-mediated CFTR overexpression on oxidative stress injury and inflammatory response in the lung tissue of COPD mouse model.
    Xu X; Huang H; Yin X; Fang H; Shen X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
    Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
    Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
    Rahman I
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant therapeutic targets in COPD.
    Rahman I; Kilty I
    Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidant metabolism in chronic obstructive pulmonary disease.
    Boots AW; Haenen GR; Bast A
    Eur Respir J Suppl; 2003 Nov; 46():14s-27s. PubMed ID: 14621103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in airways: is there a role for extracellular superoxide dismutase?
    Bowler RP; Crapo JD
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S38-43. PubMed ID: 12471087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial alterations during oxidative stress in chronic obstructive pulmonary disease.
    Jiang Y; Wang X; Hu D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1153-1162. PubMed ID: 28458526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidants and COPD.
    MacNee W
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.